Translate

Find A Doctor

Doctor Speciality Phase Type Status

Clinical Trial Title : A multi-center, prospective, open-label, single-arm, non-interventional, post marketing surveillance (PMS) study of Tresiba® (insulin degludec) to evaluate long term safety and efficacy in patients with diabetes mellitus in routine clinical practice in India

Indication : Diabetes Mellitus

Dr. Girish Parmar Endocrinology & Diabetes Registry National Completed

Clinical Trial Title : Epidemiological study to evaluate the prevalence of epidermal growth factor receptor ( EGFR ) mutation status in non-small cell lung cancer (NSCLC) in India

Indication : Non-Small Cell Lung Cancer

Dr. Rajesh Mistry Centre for Cancer Registry National Completed

Clinical Trial Title : A multicenter, prospective, observational study of lipid profiles and treatment patterns at presentation and after 12 weeks of statin therapy among Indian adults presenting with first coronary event

Indication : Coronary Artery Disease

Dr. Jamshed Dalal Centre for Cardiac Sciences Registry National Completed

Clinical Trial Title : A postmarket registry of the BioMatrix drug eluting stent

Indication : Coronary Artery Disease

Dr. Jamshed Dalal Centre for Cardiac Sciences Registry National Completed

Clinical Trial Title : Advanced Bradycardia Device Feature Utilizing and Clinical Outcomes II (Bradycare II)

Indication : Bradycardia

Dr. Jamshed Dalal Centre for Cardiac Sciences Registry National Ongoing

Clinical Trial Title : A non-interventional prospective observational Study to understand the usage pattern of Ticagrelor in Indian patients with acute coronary syndrome

Indication : Coronary Artery Disease

Dr. Jamshed Dalal Centre for Cardiac Sciences Registry National Ongoing

Clinical Trial Title : A multi-center, prospective, open-label, single-arm, non-interventional, post marketing surveillance (PMS) study of RyzodegTM (insulin degludec/insulin aspart) to evaluate long term safety and efficacy in patients with diabetes mellitus in routine clinical practice in India

Indication : Diabetes Mellitus

Dr. Dheeraj Kapoor Endocrinology & Diabetes Registry National Ongoing

Clinical Trial Title : A non-interventional prospective observational Study to understand the usage pattern of Ticagrelor in Indian patients with acute coronary syndrome

Indication : Coronary Artery Disease

Dr. Pravin Kahale Centre for Cardiac Sciences Registry National Ongoing

Clinical Trial Title : A prospective, 16 week, non-interventional, observational study to evaluate safety and tolerability in patients with severe dementia of a Alzheimer's type exposed to rivastigmine (Exelon) 15 cm2 transdermal patch

Indication : Alzheimer's Disease

Dr. Annu Aggarwal Centre for Neurosciences Registry National Ongoing

Clinical Trial Title : Reditux registry to Compare Effectiveness, safety, and resource utilization of Reditux vs. the reference medicinal product to treat Diffuse Large B-Cell Lymphoma (DLBCL) and Chronic Lymphocytic Leukaemia (CCL) in routine clinical practice

Indication : Diffuse Large B-Cell Lymphoma (DLBCL) and Chronic Lymphocytic Leukaemia (CCL)

Dr. Sameer A. Tulpule Centre for Cancer Registry National Ongoing

Clinical Trial Title : An Open-label, Single-Arm, Multicentre, Phase IV Trial to Evaluate the Safety of Firmagon® in Androgen Deprivation Therapy in Indian Patients Diagnosed with Advanced Hormone-dependent Prostate Cancer

Indication : Prostate Cancer

Dr. Yuvaraja T.B Centre for Cancer Registry National Ongoing

Clinical Trial Title : A Multicenter Registry of Pulmonary Arterial Hypertension in India

Indication : Pulmonary Arterial Hypertension

Dr. Prashant Bhobhate Children's Heart Centre Registry National Ongoing

Clinical Trial Title : A Multicentre Retrospective Study to understand anti-thrombotic treatment patterns and outcomes of Acute Coronary Syndrome patients in India

Indication : Coronary Artery Disease

Dr. Jamshed Dalal Centre for Cardiac Sciences Registry International Completed

Clinical Trial Title : An Iinternational Observational Longitudinal Registry in Outpatients with stable coronary artery disease

Indication : Coronary Artery Disease

Dr. Jamshed Dalal Centre for Cardiac Sciences Registry International Completed

Clinical Trial Title : International Registry to assess Medical Practice with Longitudinal observation for Treatment of Heart Failure

Indication : Heart Failure

Dr. Jamshed Dalal Centre for Cardiac Sciences Registry International Ongoing

Clinical Trial Title : Tetrology of Fallot Study-A large multicenter, international inception cohort study

Indication : Tetrology of Fallot

Dr. Suresh Rao Children's Heart Centre Registry International Ongoing

Clinical Trial Title : Medication Use Patterns, Treatment Satisfaction, and Inadequate Control of Osteoporosis Study (MUSIC-OS): An Asia Pacific study of postmenopausal women treated for osteoporosis in clinical practice

Indication : Osteoporosis

Dr. Jyotsna Oak Centre for Bone & Joint IV National Completed

Clinical Trial Title : An open label , multicenter study to evaluate the contraceptive efficacy , safety and acceptability of a monophasic combined oral contraceptive containing 2.5 mg nomegestrol acetate and 1.5 mg estradiol in Indian women

Indication : Contraception

Dr. Suchitra Pandit Gynaecology & Obstetrics IV National Completed

Clinical Trial Title : Contraceptive vaginal ring releasing etonogestrel and ethinylestradiol (NuvaRing): Cycle control, acceptability and tolerability study in Indian women

Indication : Contraception

Dr. Suchitra Pandit Gynaecology & Obstetrics IV National Completed

Clinical Trial Title : Long term follow-up of antithrombotic management patterns in Acute coronary syndrome patients

Indication : Coronary Artery Disease

Dr. Jamshed Dalal Centre for Cardiac Sciences IV National Completed

Clinical Trial Title : An Observational , prospective , open label study to assess effectiveness , safety and tolerability of onces-yearly treatment with zoledronic acid in osteoporotic patients in a real-world setting

Indication : Osteoporosis

Dr. Sunil Kumar Singh Centre for Bone & Joint IV National Completed

Clinical Trial Title : A Prospective, Open-labeled, Multicentric Study to Assess the Safety and Efficacy of Autologous Cultured Chondrocyte (Chondron™) in Subjects with Articular Cartilage Defects of the Knee

Indication : Articular Cartilage Injury

Dr. Dinshaw Pardiwala Centre for Bone & Joint IV National Completed

Clinical Trial Title : A Post marketing study of clinical Experience of Lipicure (Atorvastatin 80 mg) in patients with Acute Coronary Syndrome (CURE-ACS)

Indication : Coronary Artery Disease

Dr. Jamshed Dalal Centre for Cardiac Sciences IV National Completed

Clinical Trial Title : An open label, prospective, post marketing study to evaluate the safety, tolerability and efficacy of rituximab with glucocorticoids in adult patients with Wegener’s granulomatosis or microscopic polyangiitis.

Indication : Wegener’s Granulomatosis

Dr. Jyotsna Oak Centre for Bone & Joint IV National Ongoing

Clinical Trial Title : A prospective, observational study to evaluate, effectiveness and safety of fixed dose combination of Indacaterol maleate 110 mcg + Glycopyrronium bromide 50 mcg in stable Chronic Obstructive Pulmonary Disease (COPD) patients

Indication : Chronic Obstructive Pulmonary Disease

Dr. S.P Rai Pulmonary Medicine IV National Ongoing

Clinical Trial Title : A phase IV, multicenter, open-label, single-arm study of pertuzumab (in combination with trastuzumab and docetaxel) in first line treatment of Indian patients with HER2-Positive advanced (metastatic or locally recurrent) breast cancer

Indication : Breast Cancer

Dr. Mandar Nadkarni Centre for Cancer IV National Ongoing

Clinical Trial Title : A postmarketing surveillance to assess the safety of Gardasil in healthy females of 9 to 45 years in routine clinical care

Indication : Human Papilloma VirusVaccine

Dr. Suchitra Pandit Gynaecology & Obstetrics IV National Ongoing

Clinical Trial Title : Evaluation of the Safety and Effectiveness of BOTOX (Botulinum Toxin Type A) in the Treatment of Patients with Urinary Incontinence due to Neurogenic Detrusor Overactivity or Overactive Bladder. A Phase IV Non-interventional Post-marketing Surveillance Study in India

Indication : Urinary Incontinence

Dr. Sanjay Pandey Urology IV National Ongoing

Clinical Trial Title : An International Registry of Longitudinal Outcomes and Associated Cardiovascular Comordities in Patients with Rheumatoid Arthritis

Indication : Rheumatoid Arthritis

Dr. Sunil Kumar Singh Centre for Bone & Joint IV International Completed

Clinical Trial Title : A Phase 3, Randomized, Double-Blind, Active Comparator Study of the Efficacy and Safety of R-TPR-015 (1422015) in Subjects with Active Rheumatoid Arthritis on a stable dose of Methotrexate

Indication : Rheumatoid Arthritis

Dr. Sunil Kumar Singh Centre for Bone & Joint III National Completed

Clinical Trial Title : An international, double-blind, parallel-group, placebo-controlled, randomized study: evaluation of the efficacy and safety of phenobarbital as adjunctive therapy in participants (≥ 17 to 70 years old) with partial onset seizures

Indication : Seizures

Dr. Jayanti Mani Centre for Neurosciences III National Completed

Clinical Trial Title : Osteoarthritis Synvic-One ( hylan G-F 20 ) Indian PostMarketing Study - OASIS

Indication : Osteoarthritis

Dr. Dinshaw Pardiwala Centre for Bone & Joint III National Completed

Clinical Trial Title : A prospective, open label and multicentric clinical study to evaluate safety and performance of CREDENCE™ BRS Sirolimus Eluting BioResorbable Peripheral Scaffold System in subjects with de novo native peripheral artery lesions

Indication : Peripheral Artery Disease

Dr. Vimal Someshwar Interventional Radiology III National Ongoing

Clinical Trial Title : A prospective, multicentre and open label clinical study to evaluate safety and performance of CREDENCE™ BtK Sirolimus Eluting BioResorbable Peripheral Scaffold System in subjects with Critical Limb Ischemia following Percutaneous Transluminal Angioplasty of below the knee arteries

Indication : Critical Limb Ischemia

Dr. Vimal Someshwar Interventional Radiology III National Ongoing

Clinical Trial Title : A phase 3, Multicenter study to Evaluate the long- term Safety and Efficacy of Baricitinib in Patients with Rheumatoid arthritis

Indication : Rheumatoid Arthritis

Dr. Jyotsna Oak Centre for Bone & Joint III International Completed

Clinical Trial Title : A Randomized, Double-Blind, Active-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients with Moderately to Severely Active Rheumatoid Arthritis Who Have had Limited or No Treatment with Disease-Modifying Antirheumatic Drugs

Indication : Rheumatoid Arthritis

Dr. Jyotsna Oak Centre for Bone & Joint III International Completed

Clinical Trial Title : A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients with Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs with Moderately to Severely Active Rheumatoid Arthritis

Indication : Rheumatoid Arthritis

Dr. Jyotsna Oak Centre for Bone & Joint III International Completed

Clinical Trial Title : International comparative multicenter double-blind randomized clinical study of efficacy and safety of BCD-055 (CJSC BIOCAD, Russia) and Remicade® in combination with methotrexate in patients with active rheumatoid arthritis

Indication : Rheumatoid Arthritis

Dr. Sunil Kumar Singh Centre for Bone & Joint III International Completed

Clinical Trial Title : A multicenter, randomized, double-blind, placebo-controlled, 5-arm, parallel-group study to assess rotigotine transdermal system dose response in subjects with advanced-stage Parkinson’s disease

Indication : Parkinson’s Disease

Dr. Mohit Bhatt Centre for Neurosciences III International Completed

Clinical Trial Title : A Phase 3, Double-Blind, Placebo-and Active-Controlled, Dose-Range-Finding Efficacy and Safety Study of Preladenant in Subjects with Early Parkinson’s disease

Indication : Parkinson’s Disease

Dr. Mohit Bhatt Centre for Neurosciences III International Completed

Clinical Trial Title : A Phase 3, 12 Week, Double-Blind, Placebo-and Active-Controlled Efficacy and Safety Study of Preladenant in Subjects with Moderate to Severe Parkinson’s Disease

Indication : Parkinson’s Disease

Dr. Mohit Bhatt Centre for Neurosciences III International Completed

Clinical Trial Title : Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients with Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer

Indication : Non-Small Cell Lung Cancer

Dr. Rajesh Mistry Centre for Cancer III International Completed

Clinical Trial Title : Prospective, randomized, double-blind, placebo-controlled, multicenter study with an open label extension period to investigate the efficacy and safety of NT 201 in the treatment of post-stroke spaticity of the upper limb

Indication : Stroke

Dr. Mohit Bhatt Centre for Neurosciences III International Completed

Clinical Trial Title : A Randomized, Double-blind, Multi-center, Multi-national Trial to Evaluate the Efficacy, Safety, and Immunogenicity of SAIT101 Versus Rituximab as a First-line Immunotherapy Treatment in Patients with Low Tumor Burden Follicular Lymphoma

Indication : Low Tumor Burden Follicular Lymphoma

Dr. Sandeep Goyle Centre for Cancer III International Ongoing

Clinical Trial Title : A Phase III, randomized, double-blind, placebo controlled multi-center study of subcutaneous secukinumab (150 mg and 300 mg) in prefilled syringe to demonstrate efficacy (including inhibition of structural damage), safety, and tolerability up to 2 years in subjects with active psoriatic arthritis

Indication : Psoriatic Arthritis

Dr. Jyotsna Oak Centre for Bone & Joint III International Ongoing

Clinical Trial Title : A Randomized, open label, parallel group,active controlled Pharmacokinetic-Pharmacodynamic Study with Single dose of Lupin’s Rituximab and Roche’s Rituximab in patients with Rheumatoid Arthritis

Indication : Rheumatoid Arthritis

Dr. Sunil Kumar Singh Centre for Bone & Joint II International Completed

Clinical Trial Title : A Double-blind, Randomized, Parallel Group Study Comparing the Pharmacokinetics, Pharmacodynamics, Safety, Efficacy, and Immunogenicity of Three Anti-CD20 Monoclonal Antibodies in Patients with Moderate to Severe Active, Seropositive Rheumatoid Arthritis with an Inadequate Response to Methotrexate Based Therapy

Indication : Rheumatoid Arthritis

Dr. Sunil Kumar Singh Centre for Bone & Joint II International Ongoing
© 2017 Kokilaben Dhirubhai Ambani Hospital. All Rights Reserved.